Overview

Sphenopalatine Block Versus BOTOX in Management of Chronic Migraine

Status:
RECRUITING
Trial end date:
2025-10-01
Target enrollment:
Participant gender:
Summary
This trial compares the efficacy and safety of sphenopalatine ganglion block (SPGB) and intramuscular BOTOX injection in chronic migraine.
Phase:
NA
Details
Lead Sponsor:
Cairo University
Treatments:
Botulinum Toxins, Type A
Lidocaine
Sphenopalatine Ganglion Block